the study, conducted by scientists from the hiv prevention trials network, found that longacting injections once every eight weeks was better than the daily tablet used for hiv prevention.

ucwaningo, olwenziwe ngososayensi bethimba lehiv prevention trials network, luthole ukuthi ukuthola imijovo esebenza isikhathi eside kanye emva kwamaviki ayisishiyagalombili yayingcono kakhulu ukwedlula amaphilisi asetshenziselwa ukunqanda ihiv .
